CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-24 | INGRAM ROBERT ALEXANDER Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2017-05-24 | Hutson Nancy J Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2017-05-24 | Erck Stanley C Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2017-05-24 | Cohen Fred E Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2017-05-24 | ABERCROMBIE GEORGE B Director | Grant or award · Automatic Stock Option Grant | +30,000 | 30,000 | ||
| 2017-05-22 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion | +7,750 | $4.73 | $37K | 149,210 |
| 2017-05-22 | STAAB THOMAS R II Senior Vice President and CFO | Shares withheld for taxes | −6,996 | $5.24 | $37K | 142,214 |
| 2017-05-22 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion · Emp. Stock Option (Right to Buy) | −7,750 | 4,000 | ||
| 2017-03-20 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion | +3,250 | $3.78 | $12K | 144,710 |
| 2017-03-20 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,250 | $9.20 | $30K | 141,460 |
| 2017-03-20 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion · Emp. Stock Option (Right to Buy) | −3,250 | 55,805 | ||
| 2017-03-16 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion | +23,955 | $3.78 | $91K | 141,268 |
| 2017-03-16 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion | +12,500 | $1.42 | $18K | 153,768 |
| 2017-03-16 | STAAB THOMAS R II Senior Vice President and CFO | Shares withheld for taxes | −12,308 | $8.80 | $108K | 141,460 |
| 2017-03-16 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion · Emp. Stock Option (Right to Buy) | −23,955 | 59,055 | ||
| 2017-03-16 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion · Emp. Stock Option (Right to Buy) | −12,500 | 75,000 | ||
| 2017-03-10 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion | +3,250 | $3.78 | $12K | 120,563 |
| 2017-03-10 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −3,250 | $9.06 | $29K | 117,313 |
| 2017-03-10 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion · Emp. Stock Option (Right to Buy) | −3,250 | 83,010 | ||
| 2017-03-08 | STAAB THOMAS R II Senior Vice President and CFO | Exercise or conversion | +6,500 | $3.78 | $25K | 123,813 |
Page 40 of 45 · 882 trades